Skip to main content

Table 3 Subgroup analysis of sonication fluid cultures for PJI diagnosis

From: Diagnostic accuracy of sonication fluid cultures from prosthetic components in periprosthetic joint infection: an updated diagnostic meta-analysis

Subgroup analyses

No. of

studies

No. of

joints

Estimates (95% CI)

Sensitivity

Specificity

PLR

NLR

AUC

DOR

Overall studies

38

6302

0.77 (0.76–0.79)

0.96 (0.95–0.96)

18.68 (11.92–29.28)

0.24 (0.21–0.29)

0.92 (0.89–0.94)

85.65 (56.46–129.94)

Study design

Prospective

19

3081

0.78 (0.76–0.81)

0.97 (0.96–0.98)

28.46 (11.99–67.57)

0.23 (0.18–0.29)

0.91 (0.89–0.93)

134.96 (58.53–311.20)

Retrospective

17

3068

0.76 (0.74–0.79)

0.95 (0.94–0.96)

15.57 (9.85–24.61)

0.25 (0.20–0.32)

0.94 (0.91–0.95)

71.85 (47.96–107.65)

Sample site(s)

H, K, S, E or A

7

1093

0.74 (0.70–0.78)

1.00 (0.99–1.00)

114.20 (43.84–297.47)

0.25 (0.21–0.29)

0.99 (0.99–1.00)

386.56 (18.6–1077.46)

H, K, S

4

698

0.78 (0.74–0.82)

0.88 (0.84–0.91)

7.54 (5.40–1.54)

0.23 (0.19–0.28)

0.92 (0.90–0.94)

52.23 (29.86–91.34)

H, K

18

3818

0.79 (0.76–0.81)

0.97 (0.96–0.97)

19.32 (10.71–34.87)

0.22 (0.17–0.29)

0.93 (0.90–0.95)

98.18 (52.62–183.16)

H or K or S

8

617

0.76 (0.70–0.81)

0.91 (0.88–0.93)

7.41 (5.46–10.05)

0.27 (0.21–0.34)

0.87 (0.84–0.90)

34.76 (20.72–58.32)

Publication year

 ≥ 2014

27

4465

0.78 (0.76–0.80)

0.96 (0.95–0.96)

18.55 (10.88–31.62)

0.23 (0.18–0.29)

0.92 (0.90–0.94)

89.08 (51.92–152.86)

 < 2014

11

1837

0.75 (0.71–0.78)

0.96 (0.95–0.97)

19.50 (7.70–49.43)

0.28(0.24–0.32)

0.87(0.84–0.90)

81.62 (43.84–151.95)

Cutoff value

50 CFU/ml

10

1651

0.76 (0.72–0.79)

0.96 (0.95–0.97)

21.44 (9.90–46.42)

0.26 (0.17–0.40)

0.94 (0.92–0.96)

91.26 (42.43–196.31)

20 CFU/plate

6

1345

0.78 (0.74–0.82)

0.99 (0.98–1.00)

62.89 (34.98–113.07)

0.22 (0.18–0.27)

0.97 (0.95–0.98)

247.74 (129.61–473.53)

20 CFU/ml

2

93

0.75 (0.61–0.86)

0.95 (0.83–0.99)

9.97 (2.91–34.16)

0.23 (0.04–1.26)

0.50 (0.47–0.55)

49.03 (3.31–725.31)

5 CFU/plate

3

466

0.78 (0.71–0.85)

0.96 (0.94–0.98)

15.09 (2.41–94.53)

0.24 (0.16–0.35)

0.94 (0.91–0.96)

87.74 (21.74–354.16)

2 CFU/ml

2

595

0.73 (0.67–0.79)

0.99 (0.97–1.00)

50.31 (21.24–119.15)

0.27 (0.22–0.34)

0.50 (0.49–0.52)

185.54 (74.48–462.16)

Number (joints)

 ≥ 100

21

5193

0.77 (0.75–0.79)

0.97 (0.96–0.97)

31.99 (16.64–61.49)

0.23 (0.19–0.29)

0.94 (0.91–0.95)

139.61 (79.32–245.72)

 < 100

17

1109

0.78 (0.74–0.81)

0.91 (0.88–0.93)

7.93 (6.18–10.17)

0.25 (0.21–0.30)

0.87 (0.84–0.90)

37.86 (25.60–55.98)

Antibiotic use before revision

Yes

19

3799

0.79 (0.76–0.81)

0.97 (0.96–0.98)

31.24 (17.62–55.40)

0.23 (0.19–0.28)

0.93 (0.91–0.95)

132.06 (81.46–214.07)

No

13

1825

0.74 (0.71–0.77)

0.94 (0.92–0.95)

11.07 (5.28–23.24)

0.27 (0.19–0.38)

0.91 (0.88–0.93)

48.79 (21.16–112.50)

Sample processing time (after prosthesis removal)

Within 6 h

21

2794

0.75 (0.73–0.78)

0.95 (0.94–0.96)

15.09 (8.29–27.48)

0.25 (0.20–0.32)

0.92 (0.90–0.94)

66.01 (36.77–118.51)

Within 24–48 h

3

431

0.70 (0.64–0.76)

0.98 (0.95–0.99)

29.62 (11.44–76.71)

0.30 (0.25–0.37)

0.80 (0.78–0.83)

97.88 (35.62–268.93)

Patient enrollment

Consecutive

34

5742

0.77 (0.75–0.79)

0.96 (0.95–0.97)

19.16 (12.11–30.33)

0.24 (0.20–0.29)

0.92 (0.89–0.94)

87.67 (55.86–137.60)

NA (Not provided)

4

560

0.79 (0.72–0.85)

0.94 (0.91–0.96)

11.14 (7.66–16.20)

0.22 (0.17–0.30)

0.87 (0.84–0.90)

78.00 (36.93–164.74)

Solution for prosthesis

Ringer’s solution

23

4342

0.79 (0.77–0.81)

0.95 (0.94–0.96)

16.79 (9.57–29.48)

0.23 (0.18–0.29)

0.92 (0.90–0.94)

81.45 (47.75–138.95)

sterile saline

8

622

0.74 (0.68–0.79)

0.93 (0.90–0.96)

9.94 (5.17–19.10)

0.26 (0.18–0.38)

0.92 (0.89–0.94)

45.82 (20.80–100.93)

Thioglycolate broth

3

452

0.73 (0.65–0.81)

0.99 (0.98–1.00)

96.22 (27.43–337.50)

0.27 (0.20–0.36)

0.99 (0.99–1.00)

330.02 (91.33–1192.51)

Centrifugation

Yes

24

4440

0.78 (0.76–0.80)

0.96 (0.95–0.97)

20.64 (11.67–36.49)

0.23 (0.18–0.28)

0.93 (0.90–0.95)

95.53 (56.83–160.59)

No

11

1252

0.74 (0.70–0.78)

0.93 (0.91–0.95)

12.21 (5.68–26.25)

0.28 (0.21–0.37)

0.89 (0.86–0.91)

53.34 (25.25–112.72)

Vortexing

Yes

32

5261

0.78 (0.76–0.80)

0.96 (0.95–0.97)

19.08 (11.96–30.46)

0.24 (0.20–0.29)

0.92 (0.90–0.94)

87.14 (55.07–137.87)

No

3

431

0.73 (0.67–0.79)

0.87 (0.82–0.91)

7.48 (1.40–40.02)

0.29 (0.22–0.38)

0.91 (0.89–0.92)

36.54 (11.83–112.90)

Culture period

Aerobic and anaerobic (≦7d)

10

2045

0.73 (0.69–0.76)

0.98 (0.97–0.99)

33.41 (14.41–77.47)

0.27 (0.20–0.37)

0.93 (0.91–0.95)

125.03 (54.46–287.03)

Aerobic (≦7d) and anaerobic (7-14d)

15

2732

0.81 (0.79–0.84)

0.96 (0.95–0.97)

21.01 (10.93–40.39)

0.21 (0.16–0.27)

0.93 (0.91–0.95)

107.69 (54.11–214.32)

Aerobic and anaerobic (7-14d)

10

915

0.75 (0.71–0.80)

0.88 (0.85–0.91)

6.81 (3.80–12.20)

0.26 (0.18–0.37)

0.90 (0.87–0.92)

34.90 (19.12–63.70)

Reference standard

MSIS or ICM

13

 

0.81 (0.78–0.84)

0.94 (0.93–0.96)

12.41 (7.67–20.06)

0.21 (0.14–0.31)

0.94 (0.92–0.96)

68.58 (39.56–118.89)

IDSA or EBJIS

6

 

0.73 (0.69–0.77)

0.99 (0.98–1.00)

38.49 (17.73–83.54)

0.26 (0.19–0.37)

0.80 (0.77–0.83)

170.30 (61.47–471.82)

Other

19

 

0.77 (0.74–0.79)

0.95 (0.95–0.97)

20.17 (9.37–43.42)

0.26 (0.22–0.31)

0.87 (0.84–0.90)

87.12 (43.37–175.01)

Geographical location

USA

9

 

0.78 (0.74–0.81)

0.96 (0.95–0.97)

20.96 (11.04–39.78)

0.25 (0.19–0.34)

0.94 (0.92–0.96)

93.09 (51.04–169.78)

Europe

25

 

0.77 (0.75–0.79)

0.95 (0.94–0.96)

17.36 (9.74–30.94)

0.24 (0.19–0.30)

0.92 (0.89–0.94)

82.68 (46.95–145.59)

Asian

4

 

0.78 (0.72–0.84)

0.99 (0.96–1.00)

29.65 (4.37–201.33)

0.24 (0.17–0.34)

0.92 (0.89–0.94)

140.81 (25.88–766.17)

  1. NA not available; H Hip; K Knee; S Shoulder; E Elbow; A Ankle; PLR positive likelihood ratio; NLR negative likelihood ratio; AUC area under the curve; CI confidence interval; DOR diagnostic odds ratio; CFU colony-forming units; MSIS Musculoskeletal Infection Society; ICM International Consensus Meeting; IDSA Infectious Diseases Society of America; EBJIS European Bone and Joint Infection Society; d days